Chapter 5

Treatment Approaches in Covid-19 Management:Prescribing Pattern and Outcome

  • By Jalpa Suthar, Jhanvi Patel - 24 Feb 2026
  • Emerging Trends in Pharmaceutical Sciences and Clinical Studies, Volume: 1, Pages: 20 - 25

Abstract/Preface

There were various treatment approaches for the management of COVID-19, but initially, due to a lack of available information and a lack of drug availability, various drugs were prescribed to the patient. A huge difference in the first and second wave was seen. Therefore, this study is carried out to review the prescribing pattern and clinical outcome of different treatment approaches involved in COVID-19 management. A retrospective study was conducted on COVID-19-positive patients admitted to the hospital. Demographic details, presenting complaints, and diagnosis were recorded in CRF. The drug prescribing pattern was evaluated. Total 293 patients were admitted to the hospital. Out of 78 patients in 1st wave, 51(65%) patients had mild, 26(34%) had moderate, and 1(1%) had severe Covid-19 infection with no mortality. The mean age of patients was 45.3 ± 18.071 years. Common drugs prescribed during 1st wave were anti-pyretic, multivitamins, anti-inflammatory, anticoagulants, and glucocorticoids/steroids. The Mean age of patients was 53.7 ± 15.9 years. Prescribed drugs included analgesics, NSAIDS, antibiotics, immunomodulators, anticoagulants, steroids, vitamin supplements, PPIs, antihistamines, antivirals, probiotics, antiemetics, and laxatives. During the 1st and 2nd wave medicines were given according to standard treatment guidelines. Additionally, supportive and symptomatic therapy was prescribed as per patient’s comorbidities.